<!– Name:DistributionId Value:8787433 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:9500 –> <!– Name:CustomerId Value:1199976 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:e3d1da2b-221d-4656-a347-7d308bdefa12 –>
Avant! AI new release is planned in May 2023
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”, or the “Company”), through its partially owned subsidiary, GBT Tokenize Corp. (“Tokenize”), filed a federal trademark application for its Avant! AI technology. The application has been assigned serial number 97817437 with the USPTO and the filing date is March 1, 2023. GBT owns 50% of the outstanding securities of Tokenize Corp. Avant! AI is a machine learning system that interacts with users via natural language processing (NLP) technology. It includes sets of neural network algorithms that work cognitively to search and learn about a topic and respond accordingly.
Tokenize is currently working to enhance the dialog interface for Avant! AI, targeting more robust Q/A possibilities, combined with easier, and more friendly user interactions. Avant! AI belongs to an emerging generation of chat-based artificial intelligence applications family that enables user’s conversation through a chat dialog interface, allowing it to understand and respond to questions using natural language inputs. Avant! enhancements phase aims to be completed during the next few months and will be released as a web application. Tokenize’s Goal is to further develop the system to create intelligent solutions in various fields among them are medicine, cybersecurity, and communication.
“Tokenize is trademarking Avant! AI technology as it is gearing up for its new release in the next upcoming months. Since its released, Avant! core technology was used in other derivative applications, the most recent one is Hippocrates (www.hmd.care). Hippocrates is a health information system, released as a POC version, focusing on both preventative and primary care to provide first line of health-related advice and recommendations. Avant! is currently under development to enhance its NLP technology and to provide robust user’s interaction experience. Additionally, Tokenize is also equipping it with summarization techniques to provide faster and enhanced informational coverage,” provided Danny Rittman, the Company’s CTO.
GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.
Certain statements contained in this press release may constitute “forward-looking statements”. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release.